Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome.
del Río García
E
E
Rodríguez
C
C
Rodríguez-Martorell
J
J
Serrano
A
A
Girón-González
J A
JA
D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood; D008297:Male; D015539:Platelet Activation / Q000502:physiology*; D011446:Prospective Studies
D017153:Antibodies, Anticardiolipin; D016682:Lupus Coagulation Inhibitor